durvalumab,pembrolizumab,pemetrexed,cisplatin,gemcitabine
astrazeneca,merck
['imfinzi', 'keytruda', 'nsclc', 'sclc', '$mrk', '$azn', 'astrazeneca']
$mrk $azn keytruda scores phase iii nsclc win, outperforms astrazeneca s imfinzi | biospace #jobs
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities